Journal Mobile Options
Table of Contents
Vol. 30, No. 1, 2008
Issue release date: March 2008
Neuroepidemiology 2008;30:25–33
(DOI:10.1159/000115439)

Prevalence and Pattern of Cognitive Impairment in a Community Cohort of Men in South Wales: Methodology and Findings from the Caerphilly Prospective Study

Fish M. · Bayer A.J. · Gallacher J.E.J. · Bell T. · Pickering J. · Pedro S. · Dunstan F.D. · Ben-Shlomo Y. · Ebrahim S.
aDepartments of Geriatric Medicine and Neurology, and bDepartment of Epidemiology, Statistics and Public Health, Centre for Health Sciences Research, Cardiff University, Cardiff, cDepartment of Social Medicine, University of Bristol, Bristol, and dLondon School of Hygiene and Tropical Medicine, London, UK

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background/Aims: The prevalence of dementia and cognitive impairment not dementia was investigated in the Caerphilly Prospective Study cohort (men currently aged 65–84 years). Methods: Of 1,633 men eligible for cognitive screening, 1,225 (75%) were seen, with those failing the screening criteria (CAMCOG <83 or decline in CAMCOG >9) being neurologically examined. Results: For dementia, diagnosed by DSM-IV criteria, the population prevalence was 5.2% rising to 6.1% in the screened population. For cognitive impairment not dementia, the prevalence in the screened population was 15.6% giving an overall prevalence of cognitive impairment of 21.8%. Prevalence rose fivefold between ages of 65 and 84 years to reach over 50%. Conclusion: These figures are likely to underestimate actual prevalence in this population, and developing effective interventions should be a public health priority.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Lopez OL, Kuller LH, Fitzpatrick A, Ives D, Becker JT, Beauchamp N: Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology 2003;22:1–12.
  2. Ravaglia G, Forti P, Maioli F, Sacchetti L, Mariani E, Nativio V, Talerico T, Vettori C, Macini PL: Education, occupation, and prevalence of dementia: findings from the Conselice study. Dement Geriatr Cogn Disord 2002;14:90–100.
  3. Prencipe M, Casini AR, Ferretti C, Lattanzio MT, Fiorelli M, Culasso F: Prevalence of dementia in an elderly rural population: effects of age, sex, and education. J Neurol Neurosurg Psychiatry 1996;60:628–633.
  4. Roelands M, Wostyn P, Dom H, Baro F: The prevalence of dementia in Belgium: a population-based door-to-door survey in a rural community. Neuroepidemiology 1994;13:155–161.
  5. Lyketsos CG, Toone L, Tschanz J, Rabins PV, Steinberg M, Onyike CU, Corcoran C, Norton M, Zandi P, Breitner JC, Welsh-Bohmer K, Anthony J, Ostbye T, Bigler E, Pieper C, Burke J, Plassman B, Green RC, Steffens DC, Klein L, Leslie C, Townsend JJ, Wyse BW, Munger R, Williams M: Population-based study of medical comorbidity in early dementia and ‘cognitive impairment, no dementia (CIND)’: association with functional and cognitive impairment: The Cache County Study. Am J Geriatr Psychiatry 2005;13:656–664.
  6. Pandav R, Fillenbaum G, Ratcliff G, Dodge H, Ganguli M: Sensitivity and specificity of cognitive and functional screening instruments for dementia: the Indo-U.S. Dementia Epidemiology Study. J Am Geriatr Soc 2002;50:554–561.
  7. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE: Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet 1997;349:151–154.
  8. Liu HC, Lin KN, Teng EL, Wang SJ, Fuh JL, Guo NW, Chou P, Hu HH, Chiang BN: Prevalence and subtypes of dementia in Taiwan: a community survey of 5297 individuals. J Am Geriatr Soc 1995;43:144–149.
  9. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  10. Demirovic J, Prineas R, Loewenstein D, Bean J, Duara R, Sevush S, Szapocznik J: Prevalence of dementia in three ethnic groups: the South Florida program on aging and health. Ann Epidemiol 2003;13:472–478.
  11. Herrera E Jr, Caramelli P, Silveira AS, Nitrini R: Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord 2002;16:103–108.
  12. Lin RT, Lai CL, Tai CT, Liu CK, Yen YY, Howng SL: Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization. J Neurol Sci 1998;160:67–75.
  13. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D’Agostino RB, White LR: Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992;42:115–119.
  14. Andersen K, Lolk A, Nielsen H, Andersen J, Olsen C, Kragh-Sorensen P: Prevalence of very mild to severe dementia in Denmark. Acta Neurol Scand 1997;96:82–87.
  15. Berg L: Clinical Dementia Rating (CDR). Psychopharmacol Bull 1988;24:637–639.
  16. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO: Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. JAMA 1989;262:2551–2556.
  17. Fratiglioni L, Viitanen M, Backman L, Sandman PO, Winblad B: Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology 1992;11(suppl 1):29–36.
  18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
  19. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.
  20. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215–1222.
  21. Roman GC: Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 2002;203–204:7–10.
  22. Zekry D, Hauw JJ, Gold G: Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc 2002;50:1431–1438.
  23. Korczyn AD: Mixed Dementia – the Most Common Cause of Dementia. Ann N Y Acad Sci 2002;977:129–134.
  24. Gallacher JE, Elwood PC, Hopkinson C, Rabbitt PM, Stollery BT, Sweetnam PM, Brayne C, Huppert FA: Cognitive function in the Caerphilly study: associations with age social class, education and mood. Eur J Epidemiol 1999;15:161–169.
  25. Roth M, Huppert FA, Tym E: The Cambridge Examination for Mental Disorders in the Elderly. Cambridge, Cambridge University Press, 1988.
  26. Dubois B, Slachevsky A, Litvan I, Pillon B: The FAB: a Frontal Assessment Battery at bedside. Neurology 2000;55:1621–1626.
  27. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A: Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486–488.
  28. Jorm AF, Jacomb PA: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989;19:1015–1022.
  29. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
  30. Rockwood K, MacKnight C, Wentzel C, Black S, Bouchard R, Gauthier S, Feldman H, Hogan D, Kertesz A, Montgomery P: The diagnosis of ‘mixed’ dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC). Ann NY Acad Sci 2000;903:522–528.
  31. Wilson EB: Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927;22:209–212.

    External Resources

  32. Moroney JT, Bagiella E, Desmond DW, Hachinski VC, Molsa PK, Gustafson L, Brun A, Fischer P, Erkinjuntti T, Rosen W, Paik MC, Tatemichi TK: Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 1997;49:1096–1105.
  33. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–1992.
  34. Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, Ostbye T, Wolfson C, Gauthier S, Verreault R, McDowell I: Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001;57:714–716.
  35. Rockwood K, Wentzel C, Hachinski V, Hogan DB, MacKnight C, McDowell I: Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology 2000;54:447–451.
  36. White L, Petrovitch H, Ross GW, Masaki KH, Abbott RD, Teng EL, Rodriguez BL, Blanchette PL, Havlik RJ, Wergowske G, Chiu D, Foley DJ, Murdaugh C, Curb JD: Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA 1996;276:955–960.
  37. Lobo A, Dewey M, Copeland J, Dia JL, Saz P: The prevalence of dementia among elderly people living in Zaragoza and Liverpool. Psychol Med 1992;22:239–243.
  38. Ogura C, Nakamoto H, Uema T, Yamamoto K, Yonemori T, Yoshimura T: Prevalence of senile dementia in Okinawa, Japan. COSEPO Group. Study Group of Epidemiology for Psychiatry in Okinawa. Int J Epidemiol 1995;24:373–380.
  39. Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, Hofman A: Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. BMJ 1995;310:970–973.
  40. Graves AB, Larson EB, Edland SD, Bowen JD, McCormick WC, McCurry SM, Rice MM, Wenzlow A, Uomoto JM: Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project. Am J Epidemiol 1996;144:760–771.
  41. Hatada K, Okazaki Y, Yoshitake K, Takada K, Nakane Y: Further evidence of westernization of dementia prevalence in Nagasaki, Japan, and family recognition. Int Psychogeriatr 1999;11:123–138.
  42. Wang W, Wu S, Cheng X, Dai H, Ross K, Du X, Yin W: Prevalence of Alzheimer’s disease and other dementing disorders in an urban community of Beijing, China. Neuroepidemiology 2000;19:194–200.
  43. Vas CJ, Pinto C, Panikker D, Noronha S, Deshpande N, Kulkarni L, Sachdeva S: Prevalence of dementia in an urban Indian population. Int Psychogeriatr 2001;13:439–450.
  44. Suh GH, Kim JK, Cho MJ: Community study of dementia in the older Korean rural population. Aust N Z J Psychiatry 2003;37:606–612.
  45. Kim J, Jeong I, Chun JH, Lee S: The prevalence of dementia in a metropolitan city of South Korea. Int J Geriatr Psychiatry 2003;18:617–622.
  46. Tognoni G, Ceravolo R, Nucciarone B, Bianchi F, Dell’Agnello G, Ghicopulos I, Siciliano G, Murri L: From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy. Acta Neurol Scand 2005;112:65–71.
  47. Shaji S, Bose S, Verghese A: Prevalence of dementia in an urban population in Kerala, India. Br J Psychiatry 2005;186:136–140.
  48. De Ronchi D, Berardi D, Menchetti M, Ferrari G, Serretti A, Dalmonte E, Fratiglioni L: Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. Dement Geriatr Cogn Disord 2005;19:97–105.
  49. MRC CFAS writing Group: Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and prevalence of GMS organicity level in the MRC CFA Study. The Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Psychol Med 1998;28:319–335.
  50. Di Carlo A, Baldereschi M, Amaducci L, Maggi S, Grigoletto F, Scarlato G, Inzitari D: Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Geriatr Soc 2000;48:775–782.
  51. Prencipe M, Santini M, Casini AR, Pezzella FR, Scaldaferri N, Culasso F: Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population. J Neurol 2003;250:907–912.
  52. Unverzagt FW, Gao S, Baiyewu O, Ogunniyi AO, Gureje O, Perkins A, Emsley CL, Dickens J, Evans R, Musick B, Hall KS, Hui SL, Hendrie HC: Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 2001;57:1655–1662.
  53. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, McDowell I: Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793–1796.
  54. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC: Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–246.
  55. Hachinski V: Preventable senility: a call for action against the vascular dementias. Lancet 1992;340:645–648.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50